NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

CDC photo of coronavirus
UNC is the highest-ranked U.S. university for coronavirus research, according to Microsoft Academic, a public search engine for scholarly publications, journals and other literature.
Alexandria Center for Ag Tech
Two of the seven Alexandria LaunchLab $100,000 AgTech Innovation Prize finalists, TreeCo and TerMir, are based in the Triangle.
Honeybees
Researchers at UNCG are developing a unique new weapon to combat one of the major causes of honeybee declines: the parasitic mite called the Varroa destructor and the numerous viruses and other harmful pathogens it transmits.
NCBiotech awarded 13 grants and loans totaling $1.8 million to universities and bioscience companies in the third quarter of its current fiscal year.
Grifols' 233-acre manufacturing site in Clayton.
Grifols is collecting a blood product from recovered COVID-19 patients to develop a possible treatment for the coronavirus disease.
Shutterstock image of woman doing fingertip test
Four North Carolina universities have teamed up to win a $5.7 million federal grant for diabetes research.
Venture Connect Online logo
CED's Venture Connect Online starts today and runs for the next three weeks, giving over 90 growth-stage companies exposure to potential investors from around the world.
Banner logo
Banner Life Sciences, a High Point pharmaceutical company, has gained final regulatory approval of a drug for treating multiple sclerosis.
Chimerix logo
Durham-based Chimerix is another step closer to getting the final go-ahead for its novel smallpox treatment.
Chimerix logo
Durham-based Chimerix has gotten the green light from the FDA to test an investigational cancer drug to treat COVID-19 patients.
Krista Covey
First Flight Venture Center has named Krista Covey as the incubator’s new president, effective May 18. 
Heat Bio logo
For those feeling the health and economic heat from COVID-19 – and that’s just about everyone – Heat Biologics says it could soon offer up a potential solution.
LabCorp photo
A LabCorp blood test that helps identify individuals who’ve been exposed to the COVID-19 coronavirus is now broadly available.
Prototype of COVID-19 test slide
Duke University biomedical engineers are using an NSF grant to convert a rapid testing platform originally designed to detect Ebola to catch antigens to COVID-19.
RedHill logo
RedHill Biopharma, an Israeli specialty company with U.S. headquarters in Raleigh, says all six COVID-19 patients who recently received its investigative drug, opaganib, got better.